Patheon and Lonza Agree to Extend Exclusivity Period
Lonza Group AG and the Special Committee of Independent Directors of Patheon Inc. announced the extension of the exclusivity period granted to Lonza by Patheon, which had been scheduled to expire. The extension allows for continued discussions regarding possible strategic transactions between Patheon and Lonza. The period of exclusivity will continue until terminated by either party by notice to the other. Other terms of the exclusivity arrangements will continue to apply.
Lonza and Patheon are continuing to explore various strategic options that are in the best interests of the two companies. In view of the announced position of JLL Patheon Holdings LLC that it is not prepared to sell its shares of Patheon at this time, these discussions include potential transactions that do not require the sale of JLL's shares.There can be no assurance that any transaction involving the Company and Lonza will be completed or as to the terms of any such transaction.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.